1. [Hypertensive crisis].
Schmieder RE, Raff U.
MMW Fortschr Med. 2012 May 3;154(8):56-7. doi: 10.1007/s15006-012-0522-4
PMID: 22693759 German. No abstract available.

2. Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic
Resonance Imaging Study.
Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C,
Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder
RE, Eckardt KU
Kidney Int Rep. 2018 Oct 11;4(2):267-274. doi: 10.1016/j.ekir.2018.10.004.
eCollection 2019 Feb
PMID: 30775623 Free PMC article.

3. Cerebral microangiopathy in treatment-resistant hypertension.
Schmieder RE, Schmidt BM, Raff U, Bramlage P, Dörfler A, Achenbach S, Schwab J,
Kolominsky-Rabas P.
J Clin Hypertens (Greenwich). 2011 Aug;13(8):582-7. doi: 10.1111/j.1751-7176.2011.00493.x.
Epub 2011 Jul 11.
PMID: 21806768 Free PMC article.

4. Retinal capillary and arteriolar changes in patients with chronic kidney disease.
Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider
MP.
Microvasc Res. 2018 Jul;118:121-127. doi: 10.1016/j.mvr.2018.03.008. Epub 2018 Mar 17.
PMID: 29559377

5. Haemoglobin and vascular function in the human retinal vascular bed.
Ritt M, Harazny JM, Schmidt S, Raff U, Ott C, Michelson G, Schmieder RE.
J Hypertens. 2013 Apr;31(4):775-81. doi: 10.1097/HJH.0b013e32835e2ab5.
PMID: 23337471

6. Reversibility of the effects of aliskiren in the renal versus systemic circulation.
Schneider MP, Janka R, Ziegler T, Raff U, Ritt M, Ott C, Veelken R, Uder M, Schmieder
RE.
Clin J Am Soc Nephrol. 2012 Feb;7(2):258-64. doi: 10.2215/CJN.05870611. Epub 2011
Dec 15.
PMID: 22173856 Free PMC article.

7. Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.
Schneider MP, Raff U, Kopp C, Scheppach JB, Toncar S, Wanner C, Schlieper
G, Saritas T, Floege J, Schmid M, Birukov A, Dahlmann A, Linz P, Janka R, Uder
M, Schmieder RE, Titze JM, Eckardt KU.
J Am Soc Nephrol. 2017 Jun;28(6):1867-1876. doi: 10.1681/ASN.2016060662.
Epub 2017 Feb 2.
PMID: 28154199 Free PMC article.

8. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic
Kidney Disease.
Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G,
Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU,
Schneider MP.
Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.
PMID: 30354716

9. Increased Aldosterone Release During Head-Up Tilt in Early Primary
Hypertension.
Reinold A, Schneider A, Kalizki T, Raff U, Schneider MP, Schmieder RE, Schmidt BMW.
Am J Hypertens. 2017 May 1;30(5):484-489. doi: 10.1093/ajh/hpw199.
PMID: 28200011

10. Salt intake determines retinal arteriolar structure in treatment resistant
hypertension independent of blood pressure.
Raff U, Harazny JM, Titze SI, Schmidt BM, Michelson G, Schmieder RE.
Atherosclerosis. 2012 May;222(1):235-40. doi: 10.1016/j.atherosclerosis.2012.02.006.
Epub 2012 Feb 10.
PMID: 22386068

11. Low dose-eplerenone treatment decreases aortic stiffness in patients with
resistant hypertension.
Kalizki T, Schmidt BMW, Raff U, Reinold A, Schwarz TK, Schneider MP, Schmieder RE,
Schneider A.
J Clin Hypertens (Greenwich). 2017 Jul;19(7):669-676. doi: 10.1111/jch.12986.
Epub 2017 Feb 17.
PMID: 28211216 Free PMC article. Clinical Trial.

12. The effect of spironolactone on diastolic function in haemodialysis patients.
Hauser T, Dornberger V, Malzahn U, Grebe SJ, Liu D, Störk S, Nauck M, Friedrich N,
Dörr M, Wanner C, Krane V, Hammer F; MiREnDa Study Group; Collaborating
investigators (sites).
Int J Cardiovasc Imaging. 2021 Jun;37(6):1927-1936. doi: 10.1007/s10554-021-02176-5.
Epub 2021 Feb 5.
PMID: 33544240 Free PMC article. Clinical Trial.

13. Folic acid treatment normalizes NOS-dependence of vascular tone in the
metabolic syndrome.
Schneider MP, Schlaich MP, Harazny JM, Raff U, Ritt M, Ott C, Schmieder RE.
Obesity (Silver Spring). 2011 May;19(5):960-7. doi: 10.1038/oby.2010.210.
Epub 2010 Sep 23.
PMID: 20864946 Clinical Trial.

14. Gender is related to alterations of renal endothelial function in type 2 diabetes.
Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.
Nephrol Dial Transplant. 2009 Nov;24(11):3354-9. doi: 10.1093/ndt/gfp318.
Epub 2009 Jun 30.
PMID: 19567476

15. Effects of saxagliptin on early microvascular changes in patients with type 2
diabetes.
Ott C, Raff U, Schmidt S, Kistner I, Friedrich S, Bramlage P, Harazny JM, Schmieder RE.
Cardiovasc Diabetol. 2014 Jan 14;13:19. doi: 10.1186/1475-2840-13-19.
PMID: 24423149 Free PMC article. Clinical Trial.

16. Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and
progression to end stage renal disease.
Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J,
Heuschmann PU, Wanner C, Schramm L.
PLoS One. 2015 Apr 20;10(4):e0123072. doi: 10.1371/journal.pone.0123072.
eCollection 2015.
PMID: 25894587 Free PMC article.

17. Lethal varicella-zoster virus reactivation without skin lesions following renal
transplantation.
Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U.
Nephrol Dial Transplant. 2011 Jan;26(1):365-8. doi: 10.1093/ndt/gfq542.
Epub 2010 Sep 3.
PMID: 20817667

18. Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients
with arterial hypertension.
Ott C, Schneider MP, Raff U, Ritt M, Striepe K, Alberici M, Schmieder RE.
Br J Clin Pharmacol. 2013 Jan;75(1):129-35. doi: 10.1111/j.1365-2125.2012.04336.x.
PMID: 23240643 Free PMC article. Clinical Trial.

19. Postchallenge hyperglycemia is closely related with early vascular damage in
overweight and obese patients.
Schneider MP, Ott C, Ritt M, Raff U, Schlaich MP, Schmieder RE.
J Hypertens. 2012 Jan;30(1):147-52. doi: 10.1097/HJH.0b013e32834e38b6.
PMID: 22124180

20. Endogenous erythropoietin and the association with inflammation and mortality
in diabetic chronic kidney disease.
Wagner M, Alam A, Zimmermann J, Rauh K, Koljaja-Batzner A, Raff U, Wanner C,
Schramm L.
Clin J Am Soc Nephrol. 2011 Jul;6(7):1573-9. doi: 10.2215/CJN.00380111.
PMID: 21734083

21. 25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial
function and both are improved with rosuvastatin treatment.
Ott C, Raff U, Schneider MP, Titze SI, Schmieder RE.
Clin Res Cardiol. 2013 Apr;102(4):299-304. doi: 10.1007/s00392-012-0534-1.
Epub 2012 Dec 21.
PMID: 23262496 Clinical Trial.

22. Renal resistive index–a valid tool to assess renal endothelial function in humans?
Raff U, Schwarz TK, Schmidt BM, Schneider MP, Schmieder RE.
Nephrol Dial Transplant. 2010 Jun;25(6):1869-74. doi: 10.1093/ndt/gfp754.
Epub 2010 Feb 8.
PMID: 20142629

23. Central pulse pressure is an independent determinant of vascular remodeling in
the retinal circulation.
Ott C, Raff U, Harazny JM, Michelson G, Schmieder RE.
Hypertension. 2013 Jun;61(6):1340-5. doi: 10.1161/HYPERTENSIONAHA.111.00617.
Epub 2013 Apr 8.
PMID: 23569083

24. Nitric oxide and reactive hyperemia: role of location and duration of ischemia.
Raff U, Ott C, John S, Schmidt BM, Fleischmann EH, Schmieder RE.
Am J Hypertens. 2010 Aug;23(8):865-9. doi: 10.1038/ajh.2010.72. Epub 2010 Apr 15.
PMID: 20395940 Clinical Trial.

25. Renal vascular endothelial function in hypertensive patients with type 2 diabetes
mellitus.
Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE.
Am J Kidney Dis. 2009 Feb;53(2):281-9. doi: 10.1053/j.ajkd.2008.10.041.
Epub 2008 Dec 19.
PMID: 19100670

26. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces
proliferation of human vascular endothelial cells.
Heinloth A, Heermeier K, Raff U, Wanner C, Galle J.
J Am Soc Nephrol. 2000 Oct;11(10):1819-1825. doi: 10.1681/ASN.V11101819.
PMID: 11004212

27. Effects of telmisartan and ramipril on adiponectin and blood pressure in patients
with type 2 diabetes.
Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.
Am J Hypertens. 2008 Dec;21(12):1330-6. doi: 10.1038/ajh.2008.297. Epub 2008 Nov 6.
PMID: 18989258

28. First experience in analysing pulsatile retinal capillary flow and arteriolar
structural parameters measured noninvasively in hypertensive patients.
Harazny JM, Ott C, Raff U, Welzenbach J, Kwella N, Michelson G, Schmieder RE.
J Hypertens. 2014 Nov;32(11):2246-52; discussion 2252. doi:
10.1097/HJH.0000000000000308.
PMID: 25101652

29. Prevention of electrocardiographic left ventricular remodeling by the angiotensin
receptor blocker olmesartan in patients with type 2 diabetes.
Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE.
J Hypertens. 2014 Nov;32(11):2267-76; discussion 2276. doi:
10.1097/HJH.0000000000000313.
PMID: 25275251 Clinical Trial.

30. Oxidized LDL and its compound lysophosphatidylcholine potentiate
AngIIinduced vasoconstriction by stimulation of RhoA.
Galle J, Mameghani A, Bolz SS, Gambaryan S, Görg M, Quaschning T, Raff U, Barth H,
Seibold S, Wanner C, Pohl U.
J Am Soc Nephrol. 2003 Jun;14(6):1471-9. doi: 10.1097/01.asn.0000067412.18899.9b.
PMID: 12761247

31. New software analyses increase the reliability of measurements of retinal
arterioles morphology by scanning laser Doppler flowmetry in humans.
Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G,
Schmieder RE.
J Hypertens. 2011 Apr;29(4):777-82. doi: 10.1097/HJH.0b013e328343c27a.
PMID: 21297501

32. Impaired increase of retinal capillary blood flow to flicker light exposure in
arterial hypertension.
Ritt M, Harazny JM, Ott C, Raff U, Bauernschubert P, Lehmann M, Michelson G,
Schmieder RE.
Hypertension. 2012 Sep;60(3):871-6. doi: 10.1161/HYPERTENSIONAHA.112.192666.
Epub 2012 Jul 9.
PMID: 22777934

33. Olmesartan improves pulse wave velocity and lowers central systolic blood
pressure and ambulatory blood pressure in patients with metabolic syndrome.
Raff U, Walker S, Ott C, Schneider MP, Schmieder RE.
J Clin Hypertens (Greenwich). 2015 Feb;17(2):98-104. doi:
10.1111/jch.12458. Epub 2014 Dec 24.
PMID: 25537177 Free PMC article. Clinical Trial.

34. Basal nitric oxide activity is an independent determinant of arteriolar structure in
the human retinal circulation.
Ritt M, Harazny JM, Ott C, Raff U, Schneider MP, Michelson G, Schmieder RE.
J Hypertens. 2011 Jan;29(1):123-9. doi: 10.1097/HJH.0b013e3283406940.
PMID: 21045732

35. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase
of ischemic acute renal failure in rats.
Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L,
Gambaryan S, Wanner C, Schmidt HH, Galle J.
Kidney Int. 2003 Jul;64(1):216-25. doi: 10.1046/j.1523-1755.2003.00063.x.
PMID: 12787412

36. A randomized controlled trial of the effect of spironolactone on left ventricular
mass in hemodialysis patients.
Hammer F, Malzahn U, Donhauser J, Betz C, Schneider MP, Grupp C, Pollak N, Störk S,
Wanner C, Krane V; MiREnDa Study Group.
Kidney Int. 2019 Apr;95(4):983-991. doi: 10.1016/j.kint.2018.11.025. Epub 2019 Jan 31.
PMID: 30712923 Clinical Trial.

37. Influence of blood flow on arteriolar wall-to-lumen ratio in the human retinal
circulation in vivo.
Ritt M, Harazny JM, Ott C, Raff U, Lehmann M, Michelson G, Schmieder RE.
Microvasc Res. 2012 Mar;83(2):111-7. doi: 10.1016/j.mvr.2011.10.002. Epub 2011 Oct 19.
PMID: 22036673

38. Renal resistive index in addition to low-grade albuminuria complements
screening for target organ damage in therapy-resistant hypertension.
Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bär I, Schmieder RE.
J Hypertens. 2010 Mar;28(3):608-14. doi: 10.1097/HJH.0b013e32833487b8.
PMID: 20090556

39. L-Arginine does not affect renal morphology and cell survival in ischemic acute
renal failure in rats.
Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, Freund R,
Schramm L, Wanner C, Galle J.
Nephron Physiol. 2005;101(3):p39-50. doi: 10.1159/000086647. Epub 2005 Jun 30.
PMID: 15990449

40. Dihydropyridine calcium antagonists are associated with increased albuminuria
in treatment-resistant hypertensives.
Hummel D, Raff U, Schwarz TK, Schneider MP, Schmieder RE, Schmidt BM.
J Nephrol. 2010 Sep-Oct;23(5):563-8.
PMID: 20437398

raff ulrike – Search Results – PubMed (nih.gov)